Cargando…
The Use of Gabexate Mesylate and Ulinastatin for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
BACKGROUND/AIMS: Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP). Only a few pharmacologic agents have been shown to have potential efficacy for the prophylactic treatment of post-ERCP pancreatitis (PEP). The aim of this study was to determine whe...
Ejemplares similares
-
Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate
por: Chang, Jae Hyuck, et al.
Publicado: (2009) -
Effects of Gabexate Mesylate on the Gut Microbiota and Metabolomics in Rats with Sepsis
por: Sun, Wenju, et al.
Publicado: (2022) -
Endoscopic retrograde cholangiopancreatography‐related adverse events in Korea: A nationwide assessment
por: Jang, Dong Kee, et al.
Publicado: (2021) -
Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis
por: Zhu, Kun, et al.
Publicado: (2017) -
Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis
por: Kim, Ji Yeon, et al.
Publicado: (2019)